Visiting Scientist

Work address: 
Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE

Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis.

E-pub date: 30 Nov 2017

Generation and Characterisation of a Pax8-CreERT2 Transgenic Line and a Slc22a6-CreERT2 Knock-In Line for Inducible and Specific Genetic Manipulation of Renal Tubular Epithelial Cells.

E-pub date: 31 Aug 2016

Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.

E-pub date: 15 Mar 2016

Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.

E-pub date: 31 Oct 2015

A minimally invasive, lentiviral based method for the rapid and sustained genetic manipulation of renal tubules.

E-pub date: 05 Jun 2015

Germline polymorphisms and survival of lung adenocarcinoma patients: a genome-wide study in two European patient series.

E-pub date: 01 Mar 2015

Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.

E-pub date: 31 Jul 2014

Improving clinical trial recruitment: experience of a tertiary renal oncology centre.

E-pub date: 31 Aug 2013

Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.

E-pub date: 01 Jun 2013

Variation in TP63 is associated with lung adenocarcinoma in the UK population.

E-pub date: 31 Jul 2011

Chromosome 15q25 (CHRNA3-CHRNA5) variation impacts indirectly on lung cancer risk.

E-pub date: 29 Apr 2011

Single-agent carboplatin AUC10 for metastatic seminoma with IGCCCG good prognosis disease; a feasibility study of the Orchid Clinical Trials Group.

E-pub date: 31 Aug 2010

Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.

E-pub date: 01 Feb 2010

Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.

E-pub date: 31 Aug 2009

Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.

E-pub date: 15 Aug 2009

Common 5p15.33 and 6p21.33 variants influence lung cancer risk.

E-pub date: 31 Dec 2008

Identification of low penetrance alleles for lung cancer: the GEnetic Lung CAncer Predisposition Study (GELCAPS).

E-pub date: 20 Aug 2008

Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.

E-pub date: 31 May 2008

Genetic variation in the DNA repair genes is predictive of outcome in lung cancer.

E-pub date: 01 Oct 2007

Lack of evidence that p53 Arg72Pro influences lung cancer prognosis: an analysis of survival in 619 female patients.

E-pub date: 31 Aug 2007

Prognostic significance of folate metabolism polymorphisms for lung cancer.

E-pub date: 16 Jul 2007

Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis.

E-pub date: 18 Jun 2007

TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.

E-pub date: 01 Jul 2003

Show all